1. Adams R, Fredstrom B, Peets K, Hodges EV, Bowker JC, Holleb L, Gilman R. Validating a Measure of Friends' Responses to Self-Disclosure in Adolescent Obese and Public School Samples. J Clin Child Adolesc Psychol. 2016:1-12.
  2. Almeida D, Jandacek R, Weber W, McNamara R. Docosahexaenoic Acid Biostatus Is Associated with Event-Related Functional Connectivity in Cortical Attention Networks of Typically Developing Children. Nutr Neuroscience. 2016:1-9.
  3. Bowers K, Wink L, Pottenger A, McDougle C, Erickson C. Phenotypic Differences in Individuals with Autism Spectrum Disorder Born Preterm and at Term Gestation. Autism. 2015; 19:758-63.
  4. Curran RL, Badran IA, Peppers V, Pedapati EV, Correll CU, DelBello MP. Aripiprazole for the Treatment of Antipsychotic-Induced Hyperprolactinemia in an Adolescent Boy. J Child Adolesc Psychopharmacol. 2016; 26:490-1.
  5. Davenport MH, Schaefer TL, Friedmann KJ, Fitzpatrick SE, Erickson CA. Pharmacotherapy for Fragile X Syndrome: Progress to Date. Drugs. 2016; 76:431-45.
  6. Delgado S, Strawn J, Pedapati E. Contemporary Psychodynamic Psychotherapy for Children and Adolescents: Integrating Intersubjectivity and Neuroscience. New York:Springer.
  7. Delgado SV, Barzman DH. Beyond Dsm-5 and Iq Scores: Integrating the Four Pillars to Forensic Evaluations. Psychiatr Q. 2016.
  8. Erickson C, Wink L, Baindu B, Ray B, Schaefer T, Pedapati E, Lahiri D. Analysis of Peripheral Amyloid Precursor Protein in Angelman Syndrome. Am J Med Genet A. 2016; 170:2334-7.
  9. Fitzpatrick SE, Srivorakiat L, Wink LK, Pedapati EV, Erickson CA. Aggression in Autism Spectrum Disorder: Presentation and Treatment Options. Neuropsychiatr Dis Treat. 2016; 12:1525-38.
  10. Lin PI, Hsieh CD, Juan CH, Hossain MM, Erickson CA, Lee YH, Su MC. Predicting Aggressive Tendencies by Visual Attention Bias Associated with Hostile Emotions. PLoS One. 2016; 11:e0149487.
  11. McGuire K, Erickson C, Gabriels RL, Kaplan D, Mazefsky C, McGonigle J, Meservy J, Pedapati E, Pierri J, Wink L, Siegel M. Psychiatric Hospitalization of Children with Autism or Intellectual Disability: Consensus Statements on Best Practices. J Am Acad Child Adolesc Psychiatry. 2015; 54:969-71.
  12. Minshawi NF, Wink LK, Shaffer R, Plawecki MH, Posey DJ, Liu H, Hurwitz S, McDougle CJ, Swiezy NB, Erickson CA. A Randomized, Placebo-Controlled Trial of D-Cycloserine for the Enhancement of Social Skills Training in Autism Spectrum Disorders. Mol Autism. 2016; 7:2.
  13. Oberman LM, Enticott PG, Casanova MF, Rotenberg A, Pascual-Leone A, McCracken JT, T. M. S. in ASD Consensus Group. Transcranial Magnetic Stimulation in Autism Spectrum Disorder: Challenges, Promise, and Roadmap for Future Research. Autism Res. 2016; 9:184-203.
  14. Oh S, Ji H, Barzman D, Lin PI, Hutton J. Pediatric Asthma and Autism-Genomic Perspectives. Clin Transl Med. 2015; 4:37.
  15. Pedapati E, DiFrancesco M, Wu S, Giovanetti C, Nash T, Mantovani A, Ammerman R, Harris E. Neural Correlates Associated with Symptom Provocation in Pediatric Obsessive Compulsive Disorder after a Single Session of Sham-Controlled Repetitive Transcranial Magnetic Stimulation. Psychiatry Res. 2015; 233:466-73.
  16. Pedapati EV, Gilbert DL, Erickson CA, Horn PS, Shaffer RC, Wink LK, Laue CS, Wu SW. Abnormal Cortical Plasticity in Youth with Autism Spectrum Disorder: A Transcranial Magnetic Stimulation Case-Control Pilot Study. J Child Adolesc Psychopharmacol. 2016; 26:625-31.
  17. Pestian J, Grupp-Phelan J, Cohen K, Meyers G, Richey L, Matykiewicz P, Sorter M. A Controlled Trial Using Natural Language Processing to Examine the Language of Suicidal Adolescents in the Emergency Department. Suicide Life Threat Behav. 2016; 46:154-59.
  18. Schonfeld DJ, Adams RE, Fredstrom BK, Weissberg RP, Gilman R, Voyce C, Tomlin R, Speese-Linehan D. Cluster-Randomized Trial Demonstrating Impact on Academic Achievement of Elementary Social-Emotional Learning. Sch Psychol Q. 2015; 30:406-20.
  19. Siegel M, Smith KA, Mazefsky C, Gabriels RL, Erickson C, Kaplan D, Morrow EM, Wink L, Santangelo SL, Autism, Developmental Disorders Inpatient Research Collaborative. The Autism Inpatient Collection: Methods and Preliminary Sample Description. Mol Autism. 2015; 6:61.
  20. Wink L, Pedapati E, Horn P, McDougle C, Erickson C. Multiple Antipsychotic Medication Use in Autism Spectrum Disorder. J Child Adolesc Psychopharmacol. 2015.
  21. Wink LK, Adams R, Wang Z, Klaunig JE, Plawecki MH, Posey DJ, McDougle CJ, Erickson CA. A Randomized Placebo-Controlled Pilot Study of N-Acetylcysteine in Youth with Autism Spectrum Disorder. Mol Autism. 2016; 7:26.
  22. Wink LK, Badran I, Pedapati EV, Sorensen R, Benton SC, Johnson MC, Wissel G, Erickson CA. Clozapine for Drug-Refractory Irritability in Individuals with Developmental Disability. J Child Adolesc Psychopharmacol. 2016.
  23. Wink LK, Fitzpatrick S, Shaffer R, Melnyk S, Begtrup AH, Fox E, Schaefer TL, Mathieu-Frasier L, Ray B, Lahiri D, Horn PA, Erickson CA. The Neurobehavioral and Molecular Phenotype of Angelman Syndrome. Am J Med Genet A. 2015; 167A:2623-8.
  24. Xiang J, Tenney JR, Korman AM, Leiken K, Rose DF, Harris E, Yuan W, Horn PS, Holland K, Loring DW, Glauser TA. Quantification of Interictal Neuromagnetic Activity in Absence Epilepsy with Accumulated Source Imaging. Brain Topogr. 2015; 28:904-14.